ATE23537T1 - Dipeptid-derivate von 4-0, 6-0-acyl-2-amin-2deoxy-d-glucose mit immunologischer wirkung und verfahren zu ihrer herstellung. - Google Patents

Dipeptid-derivate von 4-0, 6-0-acyl-2-amin-2deoxy-d-glucose mit immunologischer wirkung und verfahren zu ihrer herstellung.

Info

Publication number: ATE23537T1
Authority: AT; Austria
Prior art keywords: alkyl; hydrogen; phenyl; substituted; image
Prior art date: 1980-04-17

Application number

AT81400608T

Other languages

English (en)

Inventor

Tsung-Ying Shen

Philippe L Durette

Conrad P Dorn Jr

James B Doherty

Richard T Dean

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-04-17

Filing date

1981-04-15

Publication date

1986-11-15

1981-04-15 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1986-11-15 Application granted granted Critical

1986-11-15 Publication of ATE23537T1 publication Critical patent/ATE23537T1/de

Links

108010016626 Dipeptides Proteins 0.000 title 1
230000001900 immune effect Effects 0.000 title 1
230000037189 immune system physiology Effects 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 12
239000001257 hydrogen Substances 0.000 abstract 12
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 7
125000000217 alkyl group Chemical group 0.000 abstract 6
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
-1 1-adamantyl Chemical group 0.000 abstract 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 3
150000002431 hydrogen Chemical class 0.000 abstract 3
125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
125000004448 alkyl carbonyl group Chemical group 0.000 abstract 2
125000000623 heterocyclic group Chemical group 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
125000000923 (C1-C30) alkyl group Chemical group 0.000 abstract 1
125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 abstract 1
125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
125000000739 C2-C30 alkenyl group Chemical group 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004849 alkoxymethyl group Chemical group 0.000 abstract 1
125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
150000003839 salts Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Crystallography & Structural Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Saccharide Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT81400608T 1980-04-17 1981-04-15 Dipeptid-derivate von 4-0, 6-0-acyl-2-amin-2deoxy-d-glucose mit immunologischer wirkung und verfahren zu ihrer herstellung. ATE23537T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/141,227 US4368190A (en)	1980-04-17	1980-04-17	Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
EP81400608A EP0038750B1 (de)	1980-04-17	1981-04-15	Dipeptid-Derivate von 4-0, 6-0-acyl-2-amin-2-deoxy-D-glucose mit immunologischer Wirkung und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number	Publication Date
ATE23537T1 true ATE23537T1 (de)	1986-11-15

Family

ID=22494746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT81400608T ATE23537T1 (de)	1980-04-17	1981-04-15	Dipeptid-derivate von 4-0, 6-0-acyl-2-amin-2deoxy-d-glucose mit immunologischer wirkung und verfahren zu ihrer herstellung.

Country Status (10)

Country	Link
US (1)	US4368190A (de)
EP (1)	EP0038750B1 (de)
JP (1)	JPS56164196A (de)
AT (1)	ATE23537T1 (de)
CA (1)	CA1174232A (de)
DE (1)	DE3175602D1 (de)
DK (1)	DK172481A (de)
ES (1)	ES8207553A1 (de)
GR (1)	GR76828B (de)
PT (1)	PT72866B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES8609353A1 (es) *	1984-05-29	1986-09-01	Ciba Geigy Ag	Procedimiento para la obtencion de un derivado del azucar
US4640911A (en) *	1985-05-29	1987-02-03	Ciba-Geigy Corporation	Acylated sugar derivatives, processes for their manufacture, and their use
US4937077A (en) *	1987-09-21	1990-06-26	Eastman Kodak Company	Method for improving feed conversion of meat-producing animals by oral administration of 2-deoxy-D-hexose
US4866035A (en) *	1987-10-05	1989-09-12	Merck & Co., Inc.	Dipeptidyl saccharides as host resistance enhancers in AIDS-immuno-compromised hosts and methods of use
US6488929B2 (en)	1994-05-23	2002-12-03	Montana State University	Candida albicans phosphomannan complex as a vaccine
US6309642B1 (en)	1997-04-28	2001-10-30	The Research And Development Institute, Inc.	Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
AU2657495A (en) *	1994-05-23	1995-12-18	Research And Development Institute, Inc.	Candida albicans adhesin as a vaccine
DE19631189A1 (de) *	1996-08-02	1998-02-05	Max Delbrueck Centrum	Neuartige kationische Amphiphile für den liposomalen Gentransfer
US20030072775A1 (en) *	1997-04-28	2003-04-17	The Research And Development Institute Inc.	Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
CN1301847A (zh) *	1999-12-27	2001-07-04	上海博德基因开发有限公司	一种新的多肽——脂肪氧化酶10和编码这种多肽的多核苷酸
CN1313389A (zh) *	2000-03-15	2001-09-19	上海博德基因开发有限公司	一种新的多肽——人脂肪氧化酶9和编码这种多肽的多核苷酸
JP5620272B2 (ja)	2007-11-09	2014-11-05	プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａＢｉｏＰｈａｒｍａＮｏｒｇｅＡＳ	化粧品において，食品サプリメントとして，または医薬品として用いるための脂質化合物
EP2147910A1 (de) *	2008-07-15	2010-01-27	Pronova BioPharma Norge AS	Neue Lipid-Verbindungen
US8735436B2 (en)	2009-05-08	2014-05-27	Pronova Biopharma Norge As	Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
CA2784748A1 (en)	2009-12-18	2011-06-23	Idenix Pharmaceuticals, Inc.	5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
UA111475C2 (uk)	2010-11-05	2016-05-10	Пронова Байофарма Нордж Ас	Способи лікування із застосуванням ліпідних сполук
AR094941A1 (es)	2013-02-28	2015-09-09	Olaf Hustvedt Svein	Una composición que comprende un compuesto lipídico, un triglicérido y un tensioactivo, y métodos para usarla
AU2016256552B2 (en)	2015-04-28	2021-04-01	Pronova Biopharma Norge As	Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
WO2019111048A1 (en)	2017-12-06	2019-06-13	Basf As	Fatty acid derivatives for treating non-alcoholic steatohepatitis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2288527A2 (fr)	1974-10-22	1976-05-21	Anvar	Compositions contenant de la n-acetyl-muramyl- l-alanyl - d-isoglutamine ou de l'acide n-acetyl-muramyl-l-alanyl - d-glutamique, exemptes d'huile et ayant des proprietes adjuvantes
SE7607300L (sv)	1975-08-13	1977-02-14	Kefalas As	Tiaxantenforeningar samt forfarande for framstellning av dem
CH613709A5 (en) *	1975-12-10	1979-10-15	Ciba Geigy Ag	Process for the preparation of glucosamine derivatives
US4082736A (en) *	1976-04-26	1978-04-04	Syntex (U.S.A.) Inc.	Novel immunological adjuvant compounds and methods of preparation thereof
CH636887A5 (en) *	1976-04-26	1983-06-30	Syntex Inc	Process for the preparation of novel immunological adjuvant compounds
US4082735A (en) *	1976-04-26	1978-04-04	Syntex (U.S.A.) Inc.	Novel immunological adjuvant compounds and methods of preparation thereof
DE2862107D1 (en) *	1977-12-02	1982-11-18	Takeda Chemical Industries Ltd	Glucosamine-peptide derivatives and their pharmaceutical compositions
JPS5479228A (en) *	1977-12-02	1979-06-25	Takeda Chem Ind Ltd	Glucosamine derivative and its preparation
JPS5479227A (en) *	1977-12-02	1979-06-25	Takeda Chem Ind Ltd	Glucosamine derivative and its preparation
EP0003833B2 (de) *	1978-02-24	1990-12-19	Ciba-Geigy Ag	Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2442241A2 (fr) *	1978-03-20	1980-06-20	Anvar	Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
JPS54130517A (en) *	1978-03-31	1979-10-09	Yuuichi Yamamura	Muramyldipeptide higher fatty acid ester
HU186585B (en) *	1978-05-18	1985-08-28	Ciba Geigy Ag	Process for producing new muramil-peptide derivatives
FR2428051A1 (fr) *	1978-06-05	1980-01-04	Anvar	Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2449697A1 (fr) *	1979-02-20	1980-09-19	Anvar	Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) *	1979-02-21	1980-08-28	Takeda Chem Ind Ltd	Glucosamine derivative and its preparation

1980
- 1980-04-17 US US06/141,227 patent/US4368190A/en not_active Expired - Lifetime
1981
- 1981-04-15 PT PT72866A patent/PT72866B/pt unknown
- 1981-04-15 AT AT81400608T patent/ATE23537T1/de not_active IP Right Cessation
- 1981-04-15 CA CA000375513A patent/CA1174232A/en not_active Expired
- 1981-04-15 DK DK172481A patent/DK172481A/da active IP Right Grant
- 1981-04-15 EP EP81400608A patent/EP0038750B1/de not_active Expired
- 1981-04-15 GR GR64701A patent/GR76828B/el unknown
- 1981-04-15 ES ES501457A patent/ES8207553A1/es not_active Expired
- 1981-04-15 DE DE8181400608T patent/DE3175602D1/de not_active Expired
- 1981-04-17 JP JP5725981A patent/JPS56164196A/ja active Pending

Also Published As

Publication number	Publication date
PT72866B (en)	1985-11-25
ES501457A0 (es)	1982-09-16
US4368190A (en)	1983-01-11
DK172481A (da)	1981-10-18
JPS56164196A (en)	1981-12-17
EP0038750B1 (de)	1986-11-12
GR76828B (de)	1984-09-04
DE3175602D1 (en)	1987-01-02
PT72866A (en)	1981-05-01
ES8207553A1 (es)	1982-09-16
EP0038750A1 (de)	1981-10-28
CA1174232A (en)	1984-09-11

Legal Events

Date	Code	Title	Description
1987-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE23537T1 (de)	1986-11-15	Dipeptid-derivate von 4-0, 6-0-acyl-2-amin-2deoxy-d-glucose mit immunologischer wirkung und verfahren zu ihrer herstellung.
YU64092A (sh)	1995-03-27	Fluoralkoksibenzamino derivati heterocikličnih jedinjenja koja sadrže azot
DK330786D0 (da)	1986-07-11	Anvendelse af n-(4-phenoxy-2,6-diisopropyl-phenyl)-n'-tert-butyl-thiourinstof til bekaempelse af hvide fluer
ATE1288T1 (de)	1982-07-15	Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel.
ATE90107T1 (de)	1993-06-15	Peptide mit collagenase hemmender wirkung.
ATE38834T1 (de)	1988-12-15	5-substituierte 1,2,4-oxadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE42282T1 (de)	1989-05-15	Aromatische verbindungen.
ATE38988T1 (de)	1988-12-15	Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE6863T1 (de)	1984-04-15	Dipeptid-derivate von 5-0,6-0-acyl-2-amin-2desoxy-d-glucofuranose und verfahren zur herstellung.
DK182783A (da)	1983-10-27	Fremgangsmaade til fremstilling af 1-carboxy-(alkanoyl eller aralkanoyl)-indolin-2-carboxylsyreestere eller salte deraf
NO983472L (no)	1998-07-28	Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
EP0202062A3 (de)	1987-08-19	Chinuclidinderivate
DK0545983T3 (da)	1994-11-28	Mellemprodukter for chelateringsmidler med forud fastsat symmetri samt fremgangsmåde til fremstilling heraf
DE3769563D1 (de)	1991-05-29	Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
HUP9800964A2 (hu)	2000-05-28	O- és S-tartalmú 6 tagú benzo-kondenzált heterociklusos vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
NO834149L (no)	1984-05-16	Fremgangsmaate for fremstilling av terapeutisk aktive 1-aroyl-5-okso-2-pyrrolidinpropansyrederivater
RU99125652A (ru)	2001-08-20	Косметический состав и способ для замедления процессов старения кожи
DE69801535D1 (de)	2001-10-11	Benzolsulfonylamin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0011845A3 (de)	1981-05-06	Haarbehandlungsmittel mit Antischuppenwirkung
JPS5283365A (en)	1977-07-12	Synthesis of novel 4-amino-5-chloro-2-methoxybenzoic acid amide deriva tives
MY102115A (en)	1992-03-31	Pyridyl compounds
ES8706617A1 (es)	1987-07-01	Metodo de preparacion de carbazatos
FR2636840B1 (fr)	1990-12-21	Sel du 6-piperidino-2,4-diaminopyrimidine-3-oxyde et de l'acide aceturique, leur preparation et leur application dermatocosmetologiques
JPS5735932A (en)	1982-02-26	Emulsifier composition
ATE7908T1 (de)	1984-06-15	4-phenoxy-3-hydroxy-butyramidoximderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel.